Wagner Wealth Management (South Carolina)’s Emergent Biosolutions EBS Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100	Closed	-$2K	–	368
2022 Q3	$2K	Hold	100	–	–	﹤0.01%	602
2022 Q2	$3K	Buy	+100	New	+$3.41K	﹤0.01%	578
2022 Q1	–	Sell	-100	Closed	-$4K	–	335
2021 Q4	$4K	Hold	100	–	–	﹤0.01%	583
2021 Q3	$5K	Hold	100	–	–	﹤0.01%	533
2021 Q2	$6K	Hold	100	–	–	﹤0.01%	546
2021 Q1	$9K	Buy	+100	New	+$10.2K	0.01%	471

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s EBS Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Emergent Biosolutions (EBS) in Q4 2022, closing a stake of 100 shares — an estimated $2K sold.

Wagner Wealth Management (South Carolina) first reported a position in EBS in Q1 2021 and held it in 6 quarters. The position peaked at $9K in Q1 2021. 196 funds tracked by Wall St. Rank hold EBS as of Q4 2022.

Wagner Wealth Management (South Carolina) reported no remaining Emergent Biosolutions position as of Q4 2022 after selling out during the quarter.
Wagner Wealth Management (South Carolina) sold 100 Emergent Biosolutions shares in Q4 2022, an estimated $2K.
Wagner Wealth Management (South Carolina) first reported a position in Emergent Biosolutions in Q1 2021 and held it in 6 quarters.
Wagner Wealth Management (South Carolina)'s Emergent Biosolutions position peaked at $9K in Q1 2021.
196 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.